PEG-liposomal oxaliplatin combined with nuclear factor-κB inhibitor (PDTC) induces apoptosis in human colorectal cancer cells

Oncology Reports

Volumn 32, Issue 4, 2014, Pages 1617-1621

  Yang, Chuang ^a,b   Fu, Zhong Xue ^b  

^a Third People's Hospital of Mianyang City   (China)

^b CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Colorectal cancer; Liposomes; Nuclear factor B; Oxaliplatin

Indexed keywords

CALCIUM ION; CASPASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXALIPLATIN; POLYETHYLENE GLYCOL LIPOSOMAL OXALIPLATIN; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P17; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; CASP3 PROTEIN, HUMAN; LIPOSOME; MACROGOL DERIVATIVE; PLATINUM COMPLEX; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CANCER COMBINATION CHEMOTHERAPY; COLORECTAL CANCER CELL LINE; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; LIPOSOMAL DELIVERY; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; UPREGULATION; WESTERN BLOTTING; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; CARCINOMA; COLORECTAL TUMOR; DRUG EFFECTS; DRUG SCREENING; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA; CASPASE 3; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LIPOSOMES; NF-KAPPA B; ORGANOPLATINUM COMPOUNDS; POLYETHYLENE GLYCOLS; PROLINE; PROTO-ONCOGENE PROTEINS C-BCL-2; THIOCARBAMATES;

EID: 84923068404     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3336     Document Type: Article

References (35)

1. Spolverato G, Ejaz A, Azad N and Pawlik TM: Surgery for colorectal liver metastases: the evolution of determining prognosis. World J Gastrointest Oncol 5: 207-221, 2013.
2. Alberts SR, Sargent DJ, Nair S, et al: Effect of oxaliplatin, fluorouracil, and leucovorin with or without cetuximab on survival among patients with resected stage III colon cancer: a randomized trial. JAMA 307: 1383-1393, 2012.
3. Garcia-Foncillas J and Diaz-Rubio E: Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome. Clin Transl Oncol 12: 533-542, 2010.
4. Jain RL and Shastri JP: Study of ocular drug delivery system using drug-loaded liposomes. Int J Pharm Investig 1: 35-41, 2011.
5. Saffari M, H Shirazi F, Oghabian MA, et al: Preparation and in-vitro evaluation of an antisense-containing cationic liposome against non-small cell lung cancer: a comparative preparation study. Iran J Pharm Res 12: 3-10, 2013.
6. Ashour AE, Abd-Allah AR, Korashy HM, et al: Thymoquinone suppression of the human hepatocellular carcinoma cell growth involves inhibition of IL-8 expression, elevated levels of TRAIL receptors, oxidative stress and apoptosis. Mol Cell Biochem 389: 85-98, 2014.
7. Nookala AR, Shah A, Noel RJ and Kumar A: HIV-1 Tat-mediated induction of CCL5 in astrocytes involves NF-κB, AP-1, C/EBPα and C/EBPγ transcription factors and JAK, PI3K/Akt and p38 MAPK signaling pathways. PLoS One 8: e78855, 2013.
8. Zhang F, Lu M, Wang H and Ren T: Aspirin attenuates angiotensin II-induced inflammation in bone marrow mesenchymal stem cells via the inhibition of ERK1/2 and NF-κB activation. Biomed Rep 1: 930-934, 2013.
9. Mezzanotte L, An N, Mol IM, Löwik CW and Kaijzel EL: A new multicolor bioluminescence imaging platform to investigate NF-κB activity and apoptosis in human breast cancer cells. PLoS One 9: e85550, 2014.
10. Krizanova O, Markova J, Pacak K, et al: Triptolide induces apoptosis through the SERCA 3 upregulation in PC12 cells. Gen Physiol Biophys 33: 137-144, 2014.
11. Anttonen M, Pihlajoki M, Andersson N, et al: FOXL2, GATA4, and SMAD3 co-operatively modulate gene expression, cell viability and apoptosis in ovarian granulosa cell tumor cells. PLoS One 9: e85545, 2014.
12. Zhuang Y, Li D, Fu J, et al: Overexpression of AIOLOS inhibits cell proliferation and suppresses apoptosis in Nalm-6 cells. Oncol Rep 31: 1183-1190, 2014.
13. Huang Y, Lu Y, Zhang L, et al: Perineural dexmedetomidine attenuates inflammation in rat sciatic nerve via the NF-κB pathway. Int J Mol Sci 15: 4049-4059, 2014.
14. Li T, Zhang Q, Zhang J, et al: Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway. BMC Cancer 14: 96, 2014.
15. Zhang J, Zhang DL, Jiao XL and Dong Q: S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal. Eur Rev Med Pharmacol Sci 17: 2372-2382, 2013.
16. Yang C, Liu HZ, Fu ZX and Lu WD: Oxaliplatin long-circulating liposomes improved therapeutic index of colorectal carcinoma. BMC Biotechnol 11: 21, 2011.
17. Yang C, Liu HZ and Fu ZX: Effects of PEG-liposomal oxaliplatin on apoptosis, and expression of Cyclin A and Cyclin D1 in colorectal cancer cells. Oncol Rep 28: 1006-1012, 2012.
18. Olszewski U and Hamilton G: A better platinum-based anticancer drug yet to come? Anticancer Agents Med Chem 10: 293-301, 2010.
19. Preiss MR and Bothun GD: Stimuli-responsive liposome-nanoparticle assemblies. Expert Opin Drug Deliv 8: 1025-1040, 2011.
20. Suntres ZE: Liposomal antioxidants for protection against oxidant-induced damage. J Toxicol 2011: 152474, 2011.
21. Pagano RE and Weinstein JN: Interactions of liposomes with mammalian cells. Annu Rev Biophys Bioeng 7: 435-468, 1978.
22. Gabizon A and Papahadjopoulos D: Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc Natl Acad Sci USA 85: 6949-6953, 1988.
23. Gabizon AA: Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet. Clin Cancer Res 7: 223-225, 2001.
24. Noble GT, Stefanick JF, Ashley JD, et al : Ligand-targeted liposome design: challenges and fundamental considerations. Trends Biotechnol 32: 32-45, 2014.
25. Hood RR, Shao C, Omiatek DM, et al: Microfluidic synthesis of PEG- and folate-conjugated liposomes for one-step formation of targeted stealth nanocarriers. Pharm Res 30: 1597-1607, 2013.
26. Abu Lila AS, Doi Y, Nakamura K, et al: Sequential administration with oxaliplatin-containing PEG-coated cationic liposomes promotes a significant delivery of subsequent dose into murine solid tumor. J Control Release 142: 167-173, 2010.
27. Vaiopoulos AG, Athanasoula KCh and Papavassiliou AG: NF-κB in colorectal cancer. J Mol Med 91: 1029-1037, 2013.
28. Li J, Li J, Yue Y, et al: Genistein suppresses tumor necrosis factor α-induced inflammation via modulating reactive oxygen species/Akt/nuclear factor κB and adenosine monophosphate-activated protein kinase signal pathways in human synoviocyte MH7A cells. Drug Des Devel Ther 8: 315-323, 2014.
29. Zha Y, Gan P, Yao Q, Ran FM and Tan J: Downregulation of Rap1 promotes 5-fluorouracil-induced apoptosis in hepatocellular carcinoma cell line HepG2. Oncol Rep 31: 1691-1698, 2014.
30. Sethi G, Ahn KS, Sung B and Aggarwal BB: Pinitol targets nuclear factor-kappaB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol Cancer Ther 7: 1604-1614, 2008.
31. Aggarwal BB: Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208, 2004.
32. Fan XX, Li N, Wu JL, et al: Celastrol induces apoptosis in gefitinib-resistant non-small cell lung cancer cells via caspases-dependent pathways and Hsp90 client protein degradation. Molecules 19: 3508-3522, 2014.
33. Park MY, Jeong YJ, Kang GC, et al: Nitric oxide-induced apoptosis of human dental pulp cells is mediated by the mitochondria-dependent pathway. Korean J Physiol Pharmacol 18: 25-32, 2014.
34. Kim MH, Kim SH and Yang WM: Beneficial effects of Astragaloside IV for hair loss via inhibition of Fas/Fas L-mediated apoptotic signaling. PLoS One 9: e92984, 2014.
35. Liu G, Wang T, Wang T, Song J and Zhou Z: Effects of apoptosis-related proteins caspase-3, Bax and Bcl-2 on cerebral ischemia rats. Biomed Rep 1: 861-867, 2013.